Product Name:Rivastigmine tartrate
Trade Name: Exelon
CAS No.:129101-54-8
Molecular Formula:C18H28N2O8
Molecular Weight: 400.42g/mol
Purity : 99.5% HPLC
Appearance: White powder
Standard Packing : 100g,1kg,25kg
Typical use :Alzheimer's disease
Shelf Life :2 years
Storage:Refrigerator away from light
Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions. Rivastigmine, a cholinesterase inhibitor, inhibits both butyrylcholinesterase and acetylcholinesterase. It is thought to work by inhibiting these cholinesterase enzymes, which would otherwise break down the brain chemical acetylcholine.
Anti-Dementia of the Alzheimer's type and dementia due to Parkinson's disease
Audited Supplier 
){kind=link}
){kind=link}